| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
46,445 |
42,815 |
$3.33M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,544 |
21,332 |
$851K |
| 92587 |
|
13,250 |
12,519 |
$830K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
8,435 |
8,097 |
$464K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,312 |
7,062 |
$411K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,845 |
5,559 |
$334K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,578 |
3,345 |
$205K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,282 |
1,162 |
$144K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,575 |
2,325 |
$122K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,595 |
1,471 |
$69K |
| 90686 |
|
5,112 |
4,926 |
$66K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,864 |
4,650 |
$62K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,998 |
2,401 |
$61K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,221 |
1,129 |
$60K |
| 90670 |
|
4,248 |
4,177 |
$47K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,314 |
4,120 |
$45K |
| 83655 |
|
2,114 |
1,928 |
$32K |
| 87081 |
|
2,732 |
2,652 |
$26K |
| 90698 |
|
2,266 |
2,243 |
$26K |
| 90697 |
|
1,728 |
1,659 |
$25K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
918 |
873 |
$25K |
| 90633 |
|
2,155 |
2,125 |
$25K |
| 90681 |
|
1,668 |
1,651 |
$19K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,187 |
1,066 |
$18K |
| 90671 |
|
1,394 |
1,323 |
$17K |
| 90651 |
|
1,437 |
1,403 |
$17K |
| 96127 |
|
3,909 |
3,595 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
511 |
492 |
$12K |
| 90744 |
|
1,188 |
1,175 |
$12K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
134 |
122 |
$12K |
| 90619 |
|
660 |
644 |
$11K |
| 94010 |
|
244 |
235 |
$9K |
| 90685 |
|
946 |
931 |
$9K |
| 80061 |
Lipid panel |
454 |
427 |
$8K |
| 92568 |
|
735 |
690 |
$8K |
| 0071A |
|
79 |
71 |
$7K |
| 90734 |
|
576 |
562 |
$7K |
| 90710 |
|
491 |
486 |
$6K |
| 99460 |
|
58 |
57 |
$6K |
| 0072A |
|
65 |
61 |
$6K |
| 90696 |
|
434 |
429 |
$5K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,099 |
1,557 |
$4K |
| 90715 |
|
342 |
332 |
$4K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,153 |
1,068 |
$4K |
| D1206 |
Topical application of fluoride varnish |
185 |
183 |
$3K |
| 85018 |
|
1,158 |
943 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,504 |
1,432 |
$3K |
| 90656 |
|
178 |
175 |
$3K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
14 |
14 |
$3K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
32 |
32 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
13 |
13 |
$2K |
| 90716 |
|
137 |
136 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
37 |
27 |
$2K |
| 90700 |
|
130 |
129 |
$1K |
| 90707 |
|
111 |
110 |
$1K |
| 82947 |
|
219 |
199 |
$1K |
| 87634 |
|
13 |
13 |
$1K |
| 90648 |
|
66 |
66 |
$933.57 |
| 94760 |
|
57 |
51 |
$674.90 |
| 17110 |
|
13 |
13 |
$672.21 |
| 90672 |
|
39 |
39 |
$628.70 |
| 81002 |
|
166 |
152 |
$599.62 |
| 69210 |
|
13 |
12 |
$442.19 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
34 |
30 |
$439.33 |
| 99401 |
|
50 |
39 |
$427.35 |
| 87807 |
|
32 |
32 |
$416.32 |
| 90660 |
|
27 |
25 |
$365.86 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
98 |
94 |
$313.82 |
| 81000 |
|
12 |
12 |
$54.24 |
| 91307 |
|
153 |
115 |
$1.34 |
| 96160 |
|
1,166 |
1,121 |
$0.00 |
| 99177 |
|
1,332 |
1,214 |
$0.00 |
| 96161 |
|
917 |
909 |
$0.00 |